Study Summary
This trial is testing a new drug to see if it's safe and effective for weight loss in obese people with or without diabetes.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: Baseline to Day 169
Trial Safety
Safety Progress
Trial Design
6 Treatment Groups
MBL949 Arm 4
1 of 6
MBL949 Arm 1
1 of 6
MBL949 Arm 5
1 of 6
MBL949 Arm 2
1 of 6
MBL949 Arm 3
1 of 6
Placebo
1 of 6
Active Control
Non-Treatment Group
127 Total Participants · 6 Treatment Groups
Primary Treatment: MBL949 Arm 4 · Has Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 60 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Tennessee | 50.0% |
| Texas | 40.0% |
| Ohio | 10.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| Novartis Investigative Site | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 77.8% |
| Did not meet criteria | 22.2% |
How many prior treatments have patients received?
| 0 | 50.0% |
| 1 | 25.0% |
| 2 | 25.0% |
What questions have other patients asked about this trial?
- "How long does this trial last?"
Why did patients apply to this trial?
- "I am eager to participate in a clinical trial that may benefit me and so many others who need to find solutions for weight loss."
How responsive is this trial?
Average response time
- < 2 Days
Typically responds via
| 100.0% | |
Most responsive sites:
- Novartis Investigative Site: < 48 hours
Frequently Asked Questions
What are the eligibility criteria for participating in this clinical experiment?
"To take part in this research, patients must be between 18 and 60 years of age and have a diagnosis of obesity. We are hoping to enrol 106 individuals for the duration of the trial." - Anonymous Online Contributor
Are recruitment efforts ongoing for this research trial?
"As per clinicaltrials.gov, this medical trial is still open for recruitment of patients. It first appeared on February 10th 2022 and was recently modified on April 5th 2022." - Anonymous Online Contributor
Is the age eligibility for this trial restricted to those over 45 years of age?
"Precisely speaking, the enrollment criteria for this medical trial necessitates that applicants are between 18 and 60 years old. Moreover, there are 203 studies available to those under 18 while 595 trials cater to individuals over 65." - Anonymous Online Contributor
How many locales are hosting this experiment?
"At present, 4 different medical centres have opened their doors to participants of this trial. These locations are based in Miami Beach, Dallas and Morehead City among others; thus it is advised that those wishing to take part select the clinic closest to them so as to abate travel costs." - Anonymous Online Contributor
Has the MBL949 Arm 4 been given a regulatory green light by the FDA?
"Although there is limited evidence to suggest the efficacy of MBL949 Arm 4, its safety has been determined by our team at Power as a 2 due to Phase 2 trials." - Anonymous Online Contributor
What is the total number of individuals participating in this experiment?
"Affirmative. Per the information present on clinicaltrials.gov, this medical trial is currently accepting applications. This study was first made public on February 10th 2022 and has been updated as recently as April 5th 2022. 106 participants are sought from 4 distinct locations for the experiment to take place." - Anonymous Online Contributor